EditorialKommentar
PRO‐C3 , liver fibrosis and CKD : The plot thickens
Liver International · 2024
DOI: 10.1111/liv.15888 ↗Kurz gefasst
Editorial in der Zeitschrift Liver International, 2024. Verfasst von Amedeo Lonardo. Beteiligte Einrichtung: Department of Internal Medicine, Azienda Ospedaliero-Universitaria di Modena (-2023), Modena, Italy. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Renal Insufficiency, ChronicNon-alcoholic Fatty Liver DiseaseHumansComplement C3Liver CirrhosisFibrosis
Stichwörter der Autor:innen
ADAPTAgile 3+MAFLD, NAFLD, PERIOD scorecollagenpropeptidessteatotic liver disease
Substanzen
Complement C3
Autor:innen und Institutionen
- Department of Internal Medicine, Azienda Ospedaliero-Universitaria di Modena (-2023), Modena, Italy.
ORCID-Profile: Amedeo Lonardo
Zitieren
APA
Lonardo, A. (2024). PRO‐C3 , liver fibrosis and CKD : The plot thickens. Liver International. https://doi.org/10.1111/liv.15888
Vancouver
Lonardo A. PRO‐C3 , liver fibrosis and CKD : The plot thickens. Liver International. 2024. doi:10.1111/liv.15888
BibTeX
@article{Lonardo2024,
author = {Lonardo, Amedeo},
title = {PRO‐C3 , liver fibrosis and CKD : The plot thickens},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.15888}
}
EUVIMED